Structures by: Siddiqui W. A.
Total: 61
<i>N</i>-(2-Ethyl-1,1-dioxo-2,3-dihydro-1<i>H</i>-1λ^6^-benzo[<i>e</i>][1,2] thiazin-4-ylidene)-<i>N</i>-(3-nitro-benzylidene)-hydrazine
C17H16N4O4S
CrystEngComm (2014) 16, 10 1963
a=10.6782(2)Å b=8.32550(10)Å c=20.3120(5)Å
α=90.00° β=105.218(3)° γ=90.00°
<i>N</i>-(1,1-Dioxo-2,3-dihydro-1<i>H</i>-1λ^6^-benzo[<i>e</i>][1,2] thiazin-4-ylidene)-<i>N</i>-(2-methyl-benzylidene)-hydrazine
C16H15N3O2S
CrystEngComm (2014) 16, 10 1963
a=14.3069(3)Å b=7.0786(2)Å c=14.4568(6)Å
α=90.00° β=91.803(2)° γ=90.00°
<i>N</i>-(1,1-Dioxo-2,3-dihydro-1<i>H</i>-1λ^6^-benzo[<i>e</i>][1,2] thiazin-4-ylidene)-<i>N</i>-(4-methyl-benzylidene)-hydrazine
C16H15N3O2S
CrystEngComm (2014) 16, 10 1963
a=7.31700(10)Å b=13.0149(2)Å c=16.1806(2)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(1,1-Dioxo-2,3-dihydro-1<i>H</i>-1λ^6^-benzo[<i>e</i>][1,2] thiazin-4-ylidene)-<i>N</i>-(3-methyl-benzylidene)-hydrazine
C16H15N3O2S
CrystEngComm (2014) 16, 10 1963
a=8.1464(3)Å b=8.3969(3)Å c=11.1659(4)Å
α=86.728(3)° β=84.540(3)° γ=86.400(3)°
4-[(1,1-Dioxo-2,3-dihydro-1<i>H</i>-1l6-benzo[<i>e</i>][1,2] thiazin-4-ylidene)-hydrazonomethyl]-2-ethoxy-phenol
C18H19N3O3S
CrystEngComm (2014) 16, 10 1963
a=14.1043(2)Å b=8.49190(10)Å c=28.3452(4)Å
α=90.00° β=93.671(2)° γ=90.00°
<i>N</i>-(1,1-Dioxo-2,3-dihydro-1<i>H</i>-1λ^6^-benzo[<i>e</i>][1,2] thiazin-4-ylidene)-<i>N</i>-(4-methoxy-benzylidene)-hydrazine
C16H15N3O3S
CrystEngComm (2014) 16, 10 1963
a=26.6368(10)Å b=7.1909(2)Å c=8.6143(3)Å
α=90.00° β=112.741(4)° γ=90.00°
<i>N</i>-(1,1-Dioxo-2,3-dihydro-1<i>H</i>-1λ^6^-benzo[<i>e</i>][1,2] thiazin-4-ylidene)-<i>N</i>-(3-methoxy-benzylidene)-hydrazine
C16H15N3O3S
CrystEngComm (2014) 16, 10 1963
a=8.2437(4)Å b=9.5959(5)Å c=11.1377(6)Å
α=95.383(4)° β=107.003(4)° γ=112.475(5)°
<i>N</i>-(2-Ethyl-1,1-dioxo-2,3-dihydro-1<i>H</i>-1λ^6^-benzo[<i>e</i>][1,2] thiazin-4-ylidene)-<i>N</i>-(4-methyl-benzylidene)-hydrazine
C18H19N3O2S
CrystEngComm (2014) 16, 10 1963
a=8.4612(3)Å b=8.3500(3)Å c=24.9103(9)Å
α=90.00° β=94.490(3)° γ=90.00°
<i>N</i>-(2-Ethyl-1,1-dioxo-2,3-dihydro-1<i>H</i>-1λ^6^-benzo[<i>e</i>][1,2] thiazin-4-ylidene)-<i>N</i>-(4-methyl-benzylidene)-hydrazine
C15H13N3O2S
CrystEngComm (2014) 16, 10 1963
a=8.5087(5)Å b=9.0853(6)Å c=19.3952(8)Å
α=89.564(4)° β=79.817(4)° γ=73.739(6)°
<i>N</i>-(2-Ethyl-1,1-dioxo-2,3-dihydro-1<i>H</i>-1λ^6^-benzo[<i>e</i>][1,2] thiazin-4-ylidene)-<i>N</i>-(4-methyl-benzylidene)-hydrazine
C15H12BrN3O2S
CrystEngComm (2014) 16, 10 1963
a=6.34070(10)Å b=16.6106(4)Å c=14.4754(3)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(1,1-Dioxo-2,3-dihydro-1<i>H</i>-1λ^6^-benzo[<i>e</i>][1,2] thiazin-4-ylidene)-<i>N</i>-(2-methoxy-benzylidene)-hydrazine
C16H15N3O3S
CrystEngComm (2014) 16, 10 1963
a=6.64540(10)Å b=10.9886(2)Å c=21.2138(4)Å
α=90.00° β=90.00° γ=90.00°
O-Sulfamoylbenzoic acid
C7H7NO4S
Acta Crystallographica Section E (2007) 63, 10 o4117-o4117
a=12.200(4)Å b=15.824(6)Å c=9.012(4)Å
α=90.00° β=100.45(2)° γ=90.00°
1-Ethyl-1H-2,1-benzothiazin-4(3H)-one 2,2-dioxide
C10H11NO3S
Acta Crystallographica Section E (2008) 64, 3 o558
a=7.0272(3)Å b=8.0448(4)Å c=9.5880(4)Å
α=99.124(3)° β=95.075(3)° γ=104.092(3)°
2-Methyl-1,2-benzisothiazol-3(2H)-one 1,1-dioxide
C8H7NO3S
Acta Crystallographica Section E (2008) 64, 4 o724
a=7.463(7)Å b=6.761(6)Å c=8.748(8)Å
α=90.00° β=103.78(3)° γ=90.00°
3,3-Dibromo-1-ethyl-1H-2,1-benzothiazin-4(3H)-one 2,2-dioxide
C10H9Br2NO3S
Acta Crystallographica Section E (2008) 64, 7 o1270
a=7.7979(5)Å b=11.9645(7)Å c=13.1231(8)Å
α=90.00° β=95.374(3)° γ=90.00°
N-Chloromethylsaccharin
C8H6ClNO3S
Acta Crystallographica Section E (2007) 63, 10 o4116-o4116
a=9.208(5)Å b=8.643(4)Å c=12.458(6)Å
α=90.00° β=107.46(2)° γ=90.00°
Methyl 3-oxo-2,3-dihydro-1,2-benzothiazole-2-acetate 1,1-dioxide
C10H9NO5S
Acta Crystallographica Section E (2008) 64, 5 o859
a=7.765(3)Å b=8.496(3)Å c=8.776(4)Å
α=104.39(2)° β=100.58(2)° γ=94.30(2)°
Tetraaquabis(2-sulfamoylbenzoato)manganese(II)
C14H20Mn1N2O12S2
Acta Crystallographica Section E (2008) 64, 10 m1293-m1294
a=15.2442(4)Å b=8.2835(2)Å c=7.9188(2)Å
α=90° β=99.9710(10)° γ=90°
3-Benzylamino-1,2-benzisothiazole 1,1-dioxide
C14H12N2O2S
Acta Crystallographica Section E (2007) 63, 10 o4001
a=7.061(3)Å b=7.052(2)Å c=24.959(11)Å
α=90.00° β=93.997(18)° γ=90.00°
2-Methyl-2H-1,2-benzothiazin-4(3H)-one 1,1-dioxide
C9H9NO3S
Acta Crystallographica Section E (2007) 63, 12 o4585-o4585
a=6.778(5)Å b=8.634(6)Å c=15.704(10)Å
α=90.00° β=90.00° γ=90.00°
Methyl N-saccharinylmethyl sulfide
C9H9NO3S2
Acta Crystallographica Section E (2008) 64, 10 o1897
a=7.550(3)Å b=17.332(8)Å c=9.455(3)Å
α=90.00° β=124.26(2)° γ=90.00°
4-Hydroxy-3-carbomethoxy-2<i>H</i>-1,2-benzothiazine 1,1-dioxide
C10H9NO5S
Acta Crystallographica Section E (2008) 64, 10 o1922
a=7.777(2)Å b=10.932(4)Å c=12.890(4)Å
α=105.569(16)° β=94.588(15)° γ=97.763(16)°
Methyl 3-hydroxy-4-oxo-3,4-dihydro-2<i>H</i>-1,2-benzothiazine-3- carboxylate 1,1-dioxide monohydrate
C10H9NO6S,H2O
Acta Crystallographica Section E (2008) 64, 10 o2045
a=7.7504(5)Å b=14.5638(9)Å c=21.0615(14)Å
α=90.00° β=90.00° γ=90.00°
1-Methyl-1H-2,1-benzothiazin-4(3H)-one 2,2-dioxide
C9H9NO3S
Acta Crystallographica Section E (2008) 64, 3 o557
a=7.4553(4)Å b=8.5437(4)Å c=8.7097(4)Å
α=67.691(2)° β=70.467(2)° γ=66.327(2)°
2-[(3,4-dimethylphenyl)carbamoyl]benzenesulfonamide
C15H16N2O3S
Acta Crystallographica Section C (2008) 64, 7 o367-o371
a=11.597(9)Å b=7.450(3)Å c=16.324(13)Å
α=90.00° β=97.29(3)° γ=90.00°
2-[(2,6-dimethylphenyl)carbamoyl]benzenesulfonamide
C15H16N2O3S
Acta Crystallographica Section C (2008) 64, 7 o367-o371
a=7.968(3)Å b=8.509(5)Å c=21.510(11)Å
α=84.30(2)° β=82.46(3)° γ=88.66(3)°
2-[(2,3-dimethylphenyl)carbamoyl]benzenesulfonamide
C15H16N2O3S
Acta Crystallographica Section C (2008) 64, 7 o367-o371
a=12.842(7)Å b=15.153(9)Å c=7.572(4)Å
α=90.00° β=91.16(4)° γ=90.00°
N-(2-chlorophenyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
C16H13ClN2O4S
Acta Crystallographica Section C (2008) 64, 1 o4-o6
a=7.970(5)Å b=10.945(6)Å c=11.133(7)Å
α=60.61(3)° β=69.81(3)° γ=86.32(2)°
N-(2-chlorophenyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
C16H13ClN2O4S
Acta Crystallographica Section C (2008) 64, 1 o4-o6
a=7.750(2)Å b=28.588(7)Å c=7.5190(10)Å
α=90.00° β=106.630(12)° γ=90.00°
2-[N-(2-chlorophenyl)carbamoyl]benzenesulfonamide
C13H11ClN2O3S
Acta Crystallographica Section C (2008) 64, 5 o286-o289
a=15.734(9)Å b=10.614(6)Å c=7.717(3)Å
α=90.00° β=90.00° γ=90.00°
2-[N-(4-chlorophenyl)carbamoyl]benzenesulfonamide
C13H11ClN2O3S
Acta Crystallographica Section C (2008) 64, 5 o286-o289
a=7.435(2)Å b=16.006(6)Å c=22.061(7)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(3,4-Dimethylphenyl)-4-hydroxy-2-methyl-2<i>H</i>-1,2-benzothiazine-3- carboxamide 1,1-dioxide
C18H18N2O4S
Acta Crystallographica Section E (2009) 65, 4 o900-o901
a=7.5458(4)Å b=8.0214(3)Å c=14.4832(7)Å
α=89.864(3)° β=79.530(2)° γ=73.812(3)°
<i>N</i>-(2,3-Dimethylphenyl)-4-hydroxy-2-methyl-2<i>H</i>-1,2-benzothiazine- 3-carboxamide 1,1-dioxide
C18H18N2O4S
Acta Crystallographica Section E (2009) 65, 3 o644-o645
a=10.2461(3)Å b=8.5421(2)Å c=19.8944(5)Å
α=90.00° β=104.8320(10)° γ=90.00°
2-Methyl-4-oxopentan-2-aminium 2-sulfamoylbenzoate
C6H14NO,C7H6NO4S
Acta Crystallographica Section E (2009) 65, 8 o1883
a=21.1917(9)Å b=6.3897(2)Å c=23.3751(11)Å
α=90° β=90° γ=90°
<i>N</i>-(3-Chlorophenyl)-1,2-benzisothiazol-3-amine 1,1-dioxide
C13H9ClN2O2S
Acta Crystallographica Section E (2010) 66, 5 o1220
a=7.2223(10)Å b=7.9138(12)Å c=11.2175(17)Å
α=96.178(6)° β=98.840(5)° γ=97.574(5)°
Sodium 2-iodobenzenesulfonate monohydrate
Na,C6H4IO3S,H2O
Acta Crystallographica Section E (2008) 64, 12 m1628
a=13.6141(4)Å b=8.8233(3)Å c=7.8493(3)Å
α=90° β=92.1710(10)° γ=90°
4-(4-Bromophenyl)-6-(4-chlorophenyl)pyrimidin-2-ylamine
C16H11BrClN3
Acta Crystallographica Section E (2009) 65, 2 o390
a=39.343(8)Å b=3.851(2)Å c=22.620(6)Å
α=90.00° β=123.81(2)° γ=90.00°
4-(2-Iodobenzenesulfonamido)benzoic acid monohydrate
C13H10INO4S,H2O
Acta Crystallographica Section E (2009) 65, 2 o230
a=13.8049(9)Å b=8.2756(5)Å c=14.7928(10)Å
α=90° β=117.472(3)° γ=90°
2-Chloro-5-(2-iodobenzenesulfonamido)benzoic acid
C13H9ClINO4S
Acta Crystallographica Section E (2009) 65, 2 o281
a=26.6375(9)Å b=8.5532(2)Å c=14.2696(5)Å
α=90° β=111.923(2)° γ=90°
<i>N</i>-(4-Methoxy-2-nitrophenyl)-<i>N</i>-(methylsulfonyl)acetamide
C10H12N2O6S
Acta Crystallographica Section E (2009) 65, 5 o941
a=7.1512(2)Å b=15.4303(5)Å c=11.3217(3)Å
α=90.00° β=91.769(2)° γ=90.00°
<i>N</i>-acetonylsaccharin
C10H9NO4S
Acta Crystallographica Section E (2009) 65, 9 o2185
a=7.475(3)Å b=8.975(4)Å c=15.923(7)Å
α=90.00° β=101.028(18)° γ=90.00°
<i>N</i>-(2-Chlorophenyl)-4-hydroxy-2<i>H</i>-1,2-benzothiazine-3-carboxamide 1,1-dioxide
C15H11ClN2O4S
Acta Crystallographica Section E (2009) 65, 9 o2279-o2280
a=10.077(2)Å b=13.818(3)Å c=21.426(4)Å
α=90.00° β=97.070(13)° γ=90.00°
<i>N</i>-Saccharinylmethyl ether
C16H12N2O7S2
Acta Crystallographica Section E (2010) 66, 4 o929
a=8.9317(4)Å b=18.3681(6)Å c=10.1942(5)Å
α=90.00° β=93.517(2)° γ=90.00°
<i>N</i>'-(2,6-Dichlorobenzylidene)-2-hydroxybenzohydrazide
C14H10Cl2N2O2
Acta Crystallographica Section E (2010) 66, 10 o2603
a=7.5029(6)Å b=23.8363(13)Å c=8.0286(7)Å
α=90.00° β=109.860(6)° γ=90.00°
4-Chloro-<i>N</i>-[(<i>E</i>)-2,4-dichlorobenzylidene]aniline
C13H8Cl3N
Acta Crystallographica Section E (2010) 66, 10 o2523
a=3.9665(3)Å b=27.639(2)Å c=11.4287(9)Å
α=90° β=99.165(3)° γ=90°
3-[(<i>E</i>)-(2,4-Dichloropbenzylidene)amino]benzoic acid
C14H9Cl2NO2
Acta Crystallographica Section E (2011) 67, 1 o157
a=7.4065(2)Å b=7.6176(3)Å c=11.5330(4)Å
α=86.946(2)° β=80.4330(10)° γ=85.833(2)°
(2-Bromophenyl)(4-hydroxy-1,1-dioxo-2<i>H</i>-1,2-benzothiazin-3-yl)methanone
C15H10BrNO4S
Acta Crystallographica Section E (2012) 68, 4 o1247
a=12.0433(4)Å b=8.5491(3)Å c=14.7841(5)Å
α=90.00° β=106.3950(19)° γ=90.00°
<i>N</i>-Benzyl-4-hydroxy-2-methyl-1,1-dioxo-2<i>H</i>-1λ^6^,2- benzothiazine-3-carboxamide
C17H16N2O4S
Acta Crystallographica Section E (2012) 68, 6 o1921
a=8.785(3)Å b=9.122(3)Å c=11.425(4)Å
α=66.61(2)° β=87.66(2)° γ=69.38(2)°
4-Hydroxy-2-methyl-1,1-dioxo-2<i>H</i>-1λ^6^,2- benzothiazine-3-carboxylic acid hemihydrate
C10H9NO5S,0.5(H2O)
Acta Crystallographica Section E (2012) 68, 3 o621-o622
a=7.1837(2)Å b=8.5847(3)Å c=17.9814(4)Å
α=87.6050(10)° β=89.713(2)° γ=87.1740(10)°
2,2'-(4-Methyl-4<i>H</i>-1,2,4-triazole-3,5-diyl)dibenzenesulfonamide
C15H15N5O4S2
Acta Crystallographica Section E (2012) 68, 3 o754
a=13.4190(6)Å b=6.9043(2)Å c=19.0498(9)Å
α=90° β=102.243(2)° γ=90°
2-(<i>N</i>-Cyclohexylcarbamoyl)benzenesulfonamide
C13H18N2O3S
Acta Crystallographica Section E (2012) 68, 2 o370
a=16.1869(5)Å b=10.8467(3)Å c=15.9353(4)Å
α=90.00° β=90.00° γ=90.00°
2-(1<i>H</i>-Benzimidazol-2-yl)-<i>N</i>-[(<i>E</i>)- (dimethylamino)methylidene]benzenesulfonamide
C16H16N4O2S
Acta Crystallographica Section E (2012) 68, 7 o2069
a=15.630(5)Å b=10.003(4)Å c=22.122(5)Å
α=90° β=110.657(5)° γ=90°
2-[2-(3-Chlorophenyl)-2-oxoethyl]-4-hydroxy-3-(3-methoxybenzoyl)- 2<i>H</i>-1λ^6^,2-benzothiazine-1,1-dione
C24H18ClNO6S
Acta Crystallographica Section E (2012) 68, 4 o980-o981
a=10.2562(3)Å b=10.9602(3)Å c=11.3861(4)Å
α=116.5460(15)° β=105.3216(13)° γ=97.2383(14)°
3-[Hydroxy(3-methoxyphenyl)methylidene]-2-(2-oxo-2-phenylethyl)- 3,4-dihydro-2<i>H</i>-1λ^6^,2-benzothiazine-1,1,4-trione
C24H19NO6S
Acta Crystallographica Section E (2012) 68, 4 o978-o979
a=17.9615(5)Å b=11.2633(3)Å c=19.5904(6)Å
α=90.00° β=90.00° γ=90.00°
2,3-Dihydro-1λ^6^,2-benzothiazine-1,1,4-trione
C8H7NO3S
Acta Crystallographica Section E (2012) 68, 5 o1306
a=8.4950(4)Å b=13.7560(5)Å c=7.6677(3)Å
α=90° β=113.2140(10)° γ=90°
(2-Chlorophenyl)(4-hydroxy-1,1-dioxo-2<i>H</i>-1,2-benzothiazin-3-yl)methanone
C15H10ClNO4S
Acta Crystallographica Section E (2012) 68, 5 o1326
a=12.1078(6)Å b=8.4057(5)Å c=14.7022(9)Å
α=90.00° β=105.541(3)° γ=90.00°
4-Hydroxy-2-methyl-1,1-dioxo-<i>N</i>-phenyl-2<i>H</i>- 1λ^6^,2-benzothiazine-3-carboxamide
C16H14N2O4S
Acta Crystallographica Section E (2012) 68, 6 o1790
a=10.502(2)Å b=7.649(3)Å c=19.235(4)Å
α=90.00° β=103.395(15)° γ=90.00°
2,6-Dibromo-4-chloroaniline
C6H4Br2ClN
Acta Crystallographica Section E (2012) 68, 6 o1904
a=13.3132(7)Å b=3.9387(2)Å c=16.5476(9)Å
α=90° β=112.318(2)° γ=90°
2-[2-(2-Bromophenyl)-2-oxoethyl]-1λ^6^,2-benzothiazole-1,1,3-trione
C15H10BrNO4S
Acta Crystallographica Section E (2012) 68, 6 o1889-o1890
a=7.574(2)Å b=13.903(4)Å c=14.814(4)Å
α=110.574(15)° β=96.936(13)° γ=93.640(14)°
Chlorido(methyl 4-oxido-2-ethyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide)(6-p-cymene)ruthenium(II)
C22H26ClNO5RuS
Organometallics (2014) 33, 19 5546
a=10.8406(3)Å b=7.6269(2)Å c=14.2269(4)Å
α=90° β=108.9980(10)° γ=90°
Chlorido(methyl 4-oxido-2-benzyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide)(?6-p-cymene)ruthenium(II)
C27H28ClNO5RuS
Organometallics (2014) 33, 19 5546
a=17.0940(5)Å b=17.4204(4)Å c=17.4423(4)Å
α=90° β=90° γ=90°